AQB
AquaBounty Technologies, Inc., a biotechnology company, focuses on enhancing productivity in the commercial aquaculture industry in the United States and Canada. The company engages in genetic, genomic, and fish health and nutrition research activities. It offers AquAdvantage Salmon, a bioengineered Atlantic salmon for human consumption; and sells conventional Atlantic salmon, salmon eggs, fry, and byproducts. The company was formerly known as Aqua Bounty Farms, Inc. and changed its name to AquaBounty Technologies, Inc. in June 2004. AquaBounty Technologies, Inc. was incorporated in 1991 and is headquartered in Maynard, Massachusetts.
AquaBounty Technologies, Inc. (AQB) is rated C (2.2/5) on Deltasharpe Prism, scored against Consumer Defensive sector peers. Its strongest pillar is Momentum (C+); its weakest is Profitability (D-). The rating has held at C for 7 weeks.
Quantitative Factor Evaluation • Updated
Prism grades are automated quantitative screens, not buy, sell or hold recommendations, and not investment advice. Data may be delayed or contain errors. Terms
Ratings of B- and above are for members.
Register free to see every rating — your first 2 weeks of Premium are on us.
Register — 2 weeks freeUnderlying Financial Metrics
Historical Factor Score Progression
| Date | Value | Growth | Profitability | Momentum | Revisions | Overall |
|---|---|---|---|---|---|---|
| 2026-11-17 | C+ (2.5) | C+ (2.5) | D- (0.9) | C+ (2.7) | C+ (2.6) | C (2.2) |
| 2026-11-10 | C+ (2.5) | C+ (2.5) | D- (1.0) | C (2.5) | C+ (2.6) | C (2.2) |
| 2026-11-03 | C+ (2.5) | C+ (2.5) | D- (1.1) | B (3.3) | C+ (2.6) | C (2.4) |
| 2026-10-27 | C+ (2.5) | C+ (2.5) | D- (1.0) | B (3.2) | C (2.4) | C (2.3) |
| 2026-10-20 | C+ (2.5) | C+ (2.5) | D- (1.0) | B (3.3) | C (2.3) | C (2.3) |